| Theme: | Globalization of Pharmaceutical/Biotech R&D |
| Time: | Saturday, June 18, 2005 |
| Location: | Montgomery County Community College, Blue Bell, Pennsylvania |
A Nobel Prize Laureate in medicine and several senior executives from the major US pharmaceutical companies will present their perspectives on current world drug R&D, with a focus on the challenges, opportunities, and globalization trends in the industry. Since this conference will be held one day prior to BIO2005 (the world's largest annual biotech convention, June 19-22, 2005 in Philadelphia), we have also invited a number of executives and officials from top Chinese pharmaceutical/biotech companies and government agencies. They will share with us the current status of drug R&D and regulatory policies in China and their growing impact on global pharmaceutical/biotech R&D. The conference will be followed by the "Shanghai Zhangjiang Night Dinner Reception" sponsored by Zhangjiang Hi-Tech Park.
Keynote Speakers
| Anthony Ford-Hutchinson, Ph.D., | Executive Vice President, Worldwide Basic Research, Merck Research Laboratories, Merck & Co., Inc. |
| Baruch S. Blumberg, M.D., Ph.D., | Nobel Prize Laureate in Medicine, Senior Advisor to President, Fox Chase Cancer Center |
| Jose V. Sartarelli, Ph.D., | Company Group Chairman, Asia-Pacific/Japan/Latin America, Johnson & Johnson Pharmaceuticals Group |
| Lance Gordon, Ph.D., | CEO, VaxGen, Inc. |
| Anthony Ford-Hutchinson, Ph.D., | Executive Vice President, Worldwide Basic Research, Merck & Co. |
| Robert R. Ruffolo, Jr., Ph.D., | President, Research & Development, Wyeth Pharmaceuticals, Senior Vice President, Wyeth Corporation |
Keynote Speakers
| Ling Chen, M.D., Ph.D., | Director-General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences |
| Ken Fong, Ph.D., | Chairman, Kenson Ventures, Founder of Clontech |
| George Blumberg, Ph.D., | Director, Blumberg Associates Limited, Oxford Centre for Innovation, Oxford, UK |
| Ling Su, M.D., Ph.D., | Director, Medical and International Pharma Development, Shanghai Roche Pharmaceuticals Ltd |
| Kewen Jin, Ph.D., | CEO, Shanghai BioExplorer |
| Nathan Xin Zhang, M.D., Ph.D., MBA, | Chairman and CEO, Sinocro Partners |
| Bill Guo, Ph.D., | CEO and President, Venturepharm Holdings Ltd. |
| Ge Li, Ph.D., | Chairman and CEO, Wuxi PharmaTech Co., Ltd |
Keynote Speakers
| Mr. Dequan Ren, | Deputy Director, China State Food Drug Administration. |
| Hongguang Wang, Ph.D., | Director-General, China National Center for Biotechnology Development, The Ministry of Science and Technology of China |
| Ming-De Yu, | Executive Chairman, China Worldbest Life Industry Co, Executive Chairman, China Pharmaceutical Enterprise Management Association and China Pharmaceutical Enterprise Directors Association |
| Huacheng Wei, MBA, | Chairman, Beijing Pharmaceutical Group Co. |
| Jingkang Shen, Ph.D., | Deputy Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
| Jing Cheng, Ph.D., | CEO and CTO, CapitalBio Corporation |
| Xian-Ping Lu, Ph.D., | Co-Founder, Director, and Chief Scientific Officer, Shenzhen Chipscreen Biosciences |
| Yin Luo, Ph.D., MBA, | President and CEO, Shanghai Genomics, Inc |
| Yongzheng Hui, | Chairmen and President of Shanghai Innovation Center of Traditional Medicine, Former Deputy Minister, The Ministry of Science and Technology of China |